1. Durham, N.C.-based medical technology company Bioventus acquired rehabilitation solutions company Bioness for $45 million upfront consideration, with up to $65 million contingent consideration.
2. Spinal implant manufacturer SeaSpine on April 1 added Shweta Singh Maniar to its board of directors.
3. SeaSpine shared its preliminary financial report for the first quarter.
4. The 9th U.S. Circuit Court of Appeals revived a lawsuit April 2 accusing Medtronic of violating the False Claims Act by misrepresenting select spine devices to the FDA for clearance.
5. The FDA approved NuVasive’s Simplify cervical artificial disc for two-level total disc replacement.
6. Ron Matricaria, chair of the Orthofix board of directors since 2014, will not seek reelection at the company’s 2021 annual meeting.
More articles on devices:
Which spine procedures are surgeons migrating to the ASC in 2021?
The next 3 years in spine: What will gain ground on fusion?
5 ways spine surgery is changing: ASCs, endoscopic surgery & more
